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Abstract
 ) .We have previously reported that receptor-recognized forms of the proteinase inhibitor a -macroglobulin a M bind2 2
 .to a distinct receptor a MSR , K ;50—100 pM, activating a signaling cascade, triggering tyrosine phosphorylation of2 d
phospholipase Cg1, and raising cytosolic pH. We have now studied the effects of a M) or a cloned and expressed2
 .receptor binding fragment RBF on protein and DNA synthesis by macrophages. A nearly linear increase in total protein
and DNA synthesis was noted at ligand concentrations up to 100 pM; thereafter, synthesis plateaued. The increase
 .1.5–2-fold in protein and DNA synthesis was similar to that observed with known growth factors such as epidermal
growth factor and platelet derived growth factor. Mutants of RBF which bind well to a MSR, also caused a similar2
increase in DNA synthesis. By contrast, mutant K1374R which binds poorly to a MSR demonstrated much less of an2
effect on DNA synthesis. Chelation of intracellular Ca2q drastically reduced protein and DNA synthesis induced by RBF or
the human growth factors. These studies suggest that activation of native a M, such as would occur during tissue injury,2
produces a molecule with properties which are similar to growth factors. q 1998 Elsevier Science B.V.
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1. Introduction
 .a -Macroglobulin a M is a member of a large2 2
superfamily which also includes the complement
components. a M reacts with proteinases of every2
mechanistic class and undergoes a major conforma-
tional change which exposes receptor recognition
sites located in the carboxyl terminus of each of its
 w x.four subunits for review, see 1,2 . Like other mem-
bers of the superfamily, each a M subunit possesses2
an internal b-cysteinyl-g-glutamyl thioester which is
directly attacked by small nucleophiles such as meth-
ylamine. This reaction also results in a major confor-
mational change in the inhibitor, exposing the recep-
w xtor recognition sites 2 . Low-density lipoprotein-re-
 .lated proteinra M receptor LRPra MR has been2 2
identified as one cellular receptor that binds not only
a M-proteinasera M-methylamine complexes2 2
 ).a M , but also several structurally and function-2
ally different ligands which do not compete with each
 w x.other for binding to the receptor for review, see 3 .
 .Receptor-associated protein RAP, M ; 39 kDar
blocks the binding of all known ligands to this recep-
w xtor 3,4 . LRPra MR is a very large cell surface2
receptor found on many cell types. This receptor has
 .a ligand binding domain 515 kDa , a single mem-
 .brane spanning domain 85 kDa and a cytoplasmic
carboxyl terminal tail. We have recently identified a
second a M receptor called the a M signaling re-2 2
 .ceptor a MSR which is distinct from LRPra MR2 2
w x )5–9 . This receptor binds a M or a cloned and2
 .expressed receptor binding fragment RBF at very
 .high affinity K ;50–100 pM . Binding to this highd
affinity site is not inhibited by RAP. Ligation of
a MSR leads to the activation of phosphatidylinosi-2
tol-specific phospholipase-C coupled to a pertussis
toxin-insensitive G protein generating inositol 1,4,5-
 .triphosphate IP and an increase in intracellular3
w 2qxcalcium, Ca . Activation of phospholipase A ,i 2
phospholipase D, and protein kinase C are also ob-
w xserved 5–10 .
Binding of a M-proteinase or -methylamine to2
macrophages is known to regulate a number of prop-
 w x.erties of these cells for review, see 2 . During
embryogenesis, pregnancy and childhood, periods
representing growth, development and differentiation,
significantly increased levels of a M are seen in the2
w xplasma 2 . We have recently reported that ligation of
a MSR with a M) or RBF stimulates tyrosine2 2
phosphorylation of phospholipase Cg1 and raises
cytosolic pH, the typical effects observed when
w xgrowth factors ligate their receptors 11 . The
agonist-induced entry of Ca2q via capacitative mech-
anisms from the extracellular medium is of major
importance in the cytosolic Ca2q signals that link
activation of various receptors on the cell surface
with the initiation and control of cell functions for
w x. 2qreview, see 12,13 . Elevated cytosolic Ca has
recently been reported to modulate specific cell cycle
w xevents and DNA synthesis 14–18 . In this communi-
cation we report that ligation of a MSR with a M-2 2
methylamine, RBF and mutants of RBF which bind
to a MSR stimulate protein and DNA synthesis in a2
dose-dependent manner. We also show that chelation
of intracellular calcium with BAPTArAM or pre-
venting Ca2q entry by eiconozole greatly reduced
DNA synthesis. Moreover, these effects were ob-
served at concentrations of ligand near the K ford
ligand binding to a MSR.2
2. Materials and methods
2.1. Materials
Human a M, a M-methylamine, RBF and its2 2
mutants K1374R, E1431V, E1431A and K1370A
w xwere prepared as previously described 5–9 . EGF
 . Sigma, St. Louis, MO , and PDGF AB R and D
.Systems, Minneapolis, MN were obtained commer-
cially. Fura-2rAM and BAPTArAM were obtained
 .from Molecular Probes Eugene, OR . All other
reagents were the highest grade commercially avail-
able.
[ 2q]2.2. Measurement of IP and Ca3 i
w 2qxChanges in IP and Ca elicited by exposure of3 i
murine peritoneal macrophages to various ligands
w xwere measured as previously described 5–9 .
2.3. Measurements of protein synthesis
Protein synthesis in macrophages stimulated with
a M, RBF, EGF, and PDGF was measured essen-2
w xtially according to Servant et al. 19 . Thioglycollate-
 5 .elicited peritoneal macrophages 4=10 cells were
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incubated in RPMI 1640 medium containing glu-
 .  .tamine 1 mM , penicillin 12.5 unitsrml , strepto-
mycin 6.5 mgrml and 0.1% fatty acid free BSA
 .Sigma, St. Louis, MO for 2 h at 378C in a humidi-
 . w xfied CO 5% incubator 5–9 . Adhered monolayers2
were washed thrice with cold HHBSS and a volume
of RPMI medium added to each monolayer. To each
w3 x well was added H leucine 2 mCirml, specific
.activity 180 Cirmmol, NEN, Boston, MA followed
by the addition of different ligands to the respective
wells and the monolayers were incubated as above
for 18 h. The incubations were terminated by aspirat-
 .ing the medium, a volume of ice-cold TCA 5% was
added and the cells were left on ice for 30 min. TCA
was removed and the monolayers washed once more
 .with cold TCA 5% followed by three washings with
cold HHBSS. Cells were dissolved in a volume of 1N
NaOH and radioactivity was determined on an aliquot
by liquid scintillation counting. When the effect on
protein synthesis of cycloheximide 20 mgrml,
.  .Sigma and actinomycin D 10 mgrml, Sigma were
studied, these compounds were added 30 min prior to
the addition of ligands and they were present during
the incubation period. In experiments where the ef-
fect of intracellular calcium was studied on protein
 .synthesis, BAPTArAM 10 mM , a chelator of intra-
 .cellular calcium or eiconozole 10 mM, Sigma , an
inhibitor of extracellular calcium entry, were added
30 min before stimulation with ligands and these
agents were present during the incubation. Other
details of measuring protein synthesis were as de-
w xscribed 19 . For protein measurements, cells incu-
bated identically but untreated, were washed and
dissolved in 0.1N NaOH and protein estimated ac-
w xcording to Bradford 20 .
2.4. Measurement of DNA synthesis
DNA synthesis in macrophages was measured es-
sentially according to the method of Charlesworth
w xand Rozengart 21 . Thioglycollate-elicited
 5 .macrophages 4=10 cells were incubated in RPMI
1640 medium containing glutamine, penicillin,
streptomycin and 0.1% fatty acid free BSA for 2 h at
 .378C in a humidified CO 5% incubator as de-2
scribed above. The monolayers were washed thrice
with ice-cold HHBSS and a volume of RPMI medium
w3 x added. To each well H thymidine 2 mCirml,
.80 Cirmmol, ARC, St. Louis, MO was added fol-
lowed by the addition of different ligands to the
respective wells. The cells were incubated as above
for 20 h and the incubation terminated by aspirating
 .the medium. A volume of cold TCA 5% was added
to each well and left on ice for 30 min. TCA was
 .removed and cells washed once more with TCA 5%
followed by washing thrice with cold HHBSS. The
cells were dissolved in 1N NaOH and radioactivity
determined on an aliquot of lysate by liquid scintilla-
tion counting. In experiments where internal calcium
 .levels were manipulated, BAPTArAM 10 mM or
 .eiconozole 10 mM were added 30 min before ligand
addition and were present during incubation. Other
details of measuring DNA synthesis were as de-
w xscribed 21 . Cellular protein was measured as de-
w xscribed above 20 .
3. Results and discussion
We have recently identified a second a M recep-2
tor which is distinct from the classical LRPra MR2
w xby a number of criteria 5–11 . Ligation of this
receptor activates a typical signaling cascade and
these effects are not blocked by a large molar excess
w xof RAP 5–11 , a protein which blocks the binding of
) w xa M and RBF to LRPra MR 3,4 . Moreover,2 2
specific mutations in RBF have a differential effect
on the binding of this ligand to either LRPra MR or2
w xa MSR 9,22,23 . The RBF mutant K1370A shows2
w xgreatly decreased binding to LRPra MR 9,22,232
while the mutant K1374R binds normally to
LRPra MR; however, this mutant binds more poorly2
w xto a MSR causing loss of signal transduction 9 .2
a MSR binding by a M) or RBF occurs at very2 2
 .high affinity K ;50–100 pM and there are ap-d
w xproximately 1500 sites per macrophage 8,9 . A simi-
lar affinity and receptor number have been observed
with human trabecular meshwork cells and rheuma-
w xtoid synovial fibroblasts 24,25 . By contrast, ligand
binding to LRPra MR is of lower affinity K ;5–2 d
. 40 nM and there are many more sites ;25 000–
. w x60 000 8,9,24,25 .
Initial studies of signal transduction employing
macrophages with a M) or RBF as the ligands were2
performed at ligand concentrations in the nM range
w x5–7 . These concentrations were in part chosen based
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on the known binding affinity of these ligands for
LRPra MR at a time when no K was yet available2 d
for a MSR ligand binding. Given the very high2
affinity of ligands for a MSR one would expect2
signal transduction to occur at concentrations in the
pM range; moreover, we have recently shown that
a M) induces DNA synthesis by rheumatoid syn-2
ovial fibroblasts at concentrations as low as 50 pM
w x25 .
3.1. a MSR ligation effects on IP synthesis and2 3
[ 2q]Ca i
These observations have led us to re-examine the
) w 2qxeffects of a M on IP generation and the Ca2 3 i
 .in murine peritoneal macrophages Fig. 1 . IP syn-3
thesis in response to a M) concentrations ranging2
from 10 pM to 200 nM were studied. As can be seen,
IP synthesis is stimulated by a M) at concentra-3 2
tions as low as 10 pM; moreover, the effect of the
ligand on IP synthesis plateaus at a concentration of3
  ..about 50 pM Fig. 1 A . No further increase in IP3
synthesis occurred in response to very high doses of
) a M in the nM range of concentration data not2
.shown . Concentrations of native a M as high a2
200 nM also cause no increase in macrophage IP3
 . w xsynthesis data not shown as previously reported 5 .
w 2qxSignificant increases in Ca also occur at ligandi
  .. w 2qxconcentrations in the pM range Fig. 1 B . Ca ,i
however, continues to increase as the ligand concen-
 .tration is raised into the nM range data not shown
consistent with our earlier observations at these higher
w xconcentrations 5 . Since IP plateaus at much lower3
w 2qxlevels than Ca , it is suggested that the initiali
w 2qx 2qincrease in Ca occurs due to IP -mediated Cai 3
mobilization from internal stores while the later more
gradual increase represents capacitative entry from
the medium. Consistent with this hypothesis, we have
previously shown that a M) ligation of macrophage2
a MSR operates by both mechanisms to increase2
w 2qx w xCa 5 . Native a M causes no increase ini 2
w 2qxmacrophage Ca at concentrations of the proteini
 .as high as 200 nM data not shown consistent with
w xour previous report 5 . The current studies demon-
strate that increased synthesis of IP and IP -depen-3 3
w 2qxdent increases in Ca occur at ligand concentra-i
tions consistent with the affinity of ligands reported
w xfor a MSR 9,10,22,24,25 .2
) w 2q xFig. 1. Effect of a M on IP and Ca levels in macrophages.2 3 i
w 2q xDetails for measurements of IP and Ca in macrophages3 i
stimulated with a M-methylamine have been described previ-2
w x )ously 5–9 . Concentrations of a M used were from 10 pM to2
200nM. Values are the mean SEM from 3 to 6 individual
experiments and are expressed as % change over basal value at
 .zero time. Panel A , changes in IP levels with increasing3
concentrations of a M). Data are shown only at ligand concen-2
trations up to 5 nM since high ligand concentrations caused no
 . w 2q xfurther increase in IP synthesis. Panel B , changes in Ca3 i
with increasing concentrations of a M). Data are shown only at2
ligand concentrations up to 5 nM.
3.2. The effect of receptor-recognized forms of a M2
on protein synthesis
The effect of a M) and RBF on macrophage2
protein synthesis was then studied at concentrations
 .ranging from 50 pM to 1 nM Fig. 2 . Protein synthe-
sis increased at a nearly linear rate up to 100 pM
concentration of either ligand; thereafter, increases in
  ..protein synthesis plateaued Fig. 2 A . The effects of
EGF and PDGF on macrophage protein synthesis
)   ..were also compared to a M and RBF Fig. 2 B .2
As can be seen, these growth factors induced compa-
rable 1.5–2-fold increases in protein synthesis. As
expected both cyclohexamide and actinomycin D in-
  ..hibited RBF-induced protein synthesis Fig. 2 B .
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Fig. 2. Receptor-recognized forms of a M and macrophage2
protein synthesis. Details for measuring protein synthesis in
macrophages under different incubation conditions are described
 . )  .  .under Section 2. Panel A , effect of a M ‘ and RBF v2
on protein synthesis. Concentrations of a M-methylaminerRBF2
used were from 50 pM to 1 nM. Values are the mean"SEM from
2 to 4 individual experiments done in quadruplicate and are
expressed as fmol new synthesisrmg total cellular protein. Panel
 .B , comparison of growth factors, a M-methylamine and RBF2
 .on protein synthesis in macrophages. The columns are: a buffer;
 .  .  .  .  .  .b RBF 50pM ; c EGF 200ngrml ; d PDGF 50 ngrml ;
 .  .e effect of cycloheximide 20 mgrml on protein synthesis
 .  .induced by RBF 50 pM ; and f effect of actinomycin D
 .  .10 mgrml on protein synthesis induced by RBF 50 pM . Val-
ues are mean"SEM from two individual experiments done in
quadruplicates and are expressed as fmol new protein
synthesisrmg total cellular protein.
3.3. The effect of receptor-recognized forms of a M2
on DNA synthesis
The effect of a M) on DNA synthesis was stud-2
ied over a ligand concentration range extending to
1 nM. Ligation of a MSR by a M) or RBF in-2 2
creased DNA synthesis in macrophages in a dose-de-
pendent manner with a plateau observed in the effect
  ..at about 10 pM ligand concentration Fig. 3 A . Na-
tive a M had no effect on DNA synthesis over this2
Fig. 3. Receptor-recognized forms of a M and macrophage2
DNA synthesis. Details for measuring DNA synthesis are de-
 . )  .scribed under Section 2. Panel A , effect of a M v and2
 .RBF ’ at ligand concentrations up to 50 pM. Data were also
obtained for ligand concentrations up to 1 nM. The higher con-
centrations are not shown since they had no further effect on
 .DNA synthesis. The effect of native a M ‘ is shown for2
comparison. Values are the mean"SEM from 2 to 4 individual
experiments done in quadruplicates and are expressed as fmol
 .DNA synthesisrmg protein. Panel B , comparison of growth
factors, RBF and binding site mutants of RBF on DNA synthesis
 .  .  .in macrophages. The columns are a buffer; b RBF 50 pM ;
 .  .  .  .  .c mutant K1374R 50 pM ; d mutant E1431V 50 pM ; e
 .  .  .  .mutant E1431A 50 pM ; f mutant K1370A 50 pM ; g EGF
 .  .  .200ngrml ; and h PDGF 50 ngrml . Values are the mean"
SEM from two individual experiments done in quadruplicates
and are expressed as fmol DNA synthesisrmg protein.
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  ..concentration range Fig. 3 A . This was also true at
 .a M concentrations as high as 1 nM data not shown .2
w xRBF mutants which bind well to a MSR 9 ; namely2
E1431V, E1431A and K1370A also caused a compa-
rable 1.5–2-fold increase in macrophage DNA syn-
  ..thesis Fig. 3 B . By contrast, RBF mutant K1374R,
w 2qxwhich only slightly raises cellular IP and Ca3 i
w xlevels in macrophages 9 demonstrated very little
  ..effect on DNA synthesis Fig. 3 B . For comparison
EGF and PDGF effects on macrophage DNA synthe-
sis were also studied. These growth factors caused a
comparable 1.5–2-fold increase in DNA synthesis
  ..Fig. 3 B .
It is concluded that receptor-recognized forms of
a M exert effects on cellular DNA synthesis compa-2
rable to well known growth factors. These observa-
tions support our previous hypothesis that activation
of a M results in a molecule which has growth2
w xfactor-like properties 11,25,26 . a M is an ex-2
tremely ancient and highly conserved protein which
has been present in the animal kingdom for over
w x600 000 000 years 1,2 . It is suggested that this
molecule has evolved not only to protect organisms
from proteolytic injury, but to trigger cellular repair
and growth mechanisms in response to such potential
injury.
[ 2q]3.4. The effect of intracellular Ca le˝els on RBFi
and growth factor-induced protein and DNA synthe-
sis
There is a growing body of literature coupling the
capacitative entry of Ca2q into cells as well as intra-
cellular Ca2q mobilization on a vast number of func-
tions requiring DNA and protein synthesis. Ca2q
mobilization has been implicated in lymphocyte and
fibroblast mitogenesis, post-translational processing
and trafficking of newly synthesized lysosomal and
membrane proteins, modulation of specific cell cycle
events and reinitiation of DNA synthesis in 3T3 cells
 w x.see for example 14–18,21 . Addition of thapsigar-
gin and tBHQ to Swiss 3T3 cells at lower concentra-
tions can cause reinitiation of DNA synthesis in
synergy with either phorbol 12,13 dibutyrate or
w xbombesin 21 . At higher concentrations, these agents
inhibit both DNA and protein synthesis in DDT1
MF-2 smooth muscle cells where cell growth has
2q w xbeen linked to intracellular Ca pool contents 15 .
Ligation of a MSR with a M) and RBF raises2 2
w 2qxCa by depleting intracellular calcium pools in ani
w xIP -dependent manner 5–11 . The depletion of cal-3
cium pools triggers the entry of calcium from the
w xexternal medium 5 . Preloading of macrophages with
 . w xBAPTArAM a chelator of internal calcium 27 or
 . w xeiconozole an inhibitor of calcium entry 21,28
30 min prior to the addition of RBF, inhibited protein
  ..synthesis by about 30% Fig. 4 A and DNA synthe-
  ..sis by 60 and 51%, respectively Fig. 4 B . Treat-
ment of macrophages with thapsigargin or EGTA
prior to addition of RBF profoundly reduced protein
  .  ..and DNA synthesis Fig. 4 A and B . Likewise
when macrophages were preloaded with
BAPTArAM or eiconozole prior to the addition of
EGF and PDGF, drastic decreases in DNA synthesis
  ..were noted Fig. 4 C . The mechanism by which
intracellular Ca2q levels regulates protein and DNA
synthesis induced by receptor-recognized forms of
a M are not understood, but the results presented2
here confirm recent reports in other cell types on the
role of intracellular Ca2q levels in cellular protein
and DNA synthesis.
The effects observed in this study, such as the
maximal increase in IP synthesis induced by a M)3 2
occurred at or below the K for ligand binding tod
a MSR. This is typical of the effects seen when2
hormones or growth factors bind to their receptors
 w x.see for example 29–33 . The purpose of the
‘‘spare’’ receptors is unknown, although in part this
may be necessary to allow for changing rates of
endocytosis of receptor–ligand complexes under dif-
ferent states of the cell. For example, febrile states
may increase the rate of endocytosis. In some sys-
tems, disulfide interchange occurs between the recep-
w xtor and ligand. This was first shown with insulin 29
where the amount of insulin forming a covalent
disulfide bond with the receptor was about 10%, a
value close to the number of receptors which must be
occupied by insulin to achieve a maximal effect.
Tissue-derived macrophages are generally consid-
ered terminally differentiated cells which show little
ability to proliferate. However, in response to a num-
ber of growth factors and phorbol esters these cells
w xare capable of DNA synthesis and replication 34–40 .
The magnitude of the response to a M) seen in this2
study is most consistent with the activation of a small
subset of the macrophage population. Macrophages
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are well known to exist in a large number of activa-
tion states and to consist of a variety of cell variants
 w x.see for example 35 . These cells express various
surface markers in common and share a number of
similar properties. They do, however, have signifi-
cantly different properties as subsets including anti-
w xfungal activity and the ability to kill tumor cells 35 .
It is also unclear at present whether the macrophage
population responding to PDGF or EGF represent the
same subset of the macrophage population. The pre-
sent studies suggest that in biological systems, the
role of a M may not be confined to proteinase2
inhibition. Once exposed to proteinase attack, a M2
assumes properties like a growth factor, at least with
respect to macrophage behavior. a M, therefore may,2
serve as a sensor for tissue injury allowing
macrophages to initiate appropriate defense mecha-
nisms.
Fig. 4. Modulation of DNA synthesis by intracellular Ca2q
levels. Details for measuring protein and DNA synthesis in
macrophages under different conditions are described under Sec-
 . 2qtion 2. Panel A , the effect of intracellular Ca concentration
 .  .on protein synthesis. The columns are: a buffer; b RBF
 .  .  . 2q 50 pM ; c RBF 50 pM with 1 mM Ca added 5 min prior to
.  .  . the addition of RBF ; d RBF 50 M with 2 mM EGTA added
.  . 5 min prior to the addition of RBF ; e thapsigargin 200nM,
.  .added 30min prior to the addition of RBF ; f BAPTArAM
 .  .10 mM, added 30 min prior to addition of RBF ; and g eicono-
 .zole 10 mM, added 30 min prior to addition of RBF . Values are
the mean"SEM from two individual experiments done in qua-
druplicates and are expressed as fmol new synthesisrmg total
 . 2qcellular protein. Panel B , the effect of intracellular Ca con-
centration on DNA synthesis induced by RBF. The columns are:
 .  .  .  .  .a buffer; b RBF 50 pM ; c BAPTArAM 10 mM, 30 min ;
 .  .  . d eiconozole 10 mM, 30 min ; e BAPTArAM 10 mM, added
.  . 30 min prior to the addition of RBF ; and f eiconozole 10 mM,
.added 30 min prior to the addition of RBF . Values are the
mean"SEM from two individual experiments done in quadrupli-
cates and are expressed as fmol DNA synthesisrmg protein.
 . 2qPanel C , the effect of intracellular Ca concentration on DNA
 .synthesis induced by growth factors. The columns are: a buffer;
 .  .  .  .b EGF 200ngrml ; c BAPTArAM 10 mM plus EGF
 .  .  .  .  .200ngrml ; d eiconozole 10 mM plus EGF 200ngrml ; e
 .  .  .PDGF 50 ngrml ; f BAPTArAM 10 mM plus PDGF
 .  .  .  .50 ngrml ; g eiconozole 10 mM plus PDGF 50 ngrml .
BAPTArAM eiconozole were added 30 min prior to the addi-
tions of agonists. Values are the mean"SEM from two individ-
ual experiments done in quadruplicates.
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